The merger of 7wireVentures portfolio company Livongo and Teladoc represents a milestone in digital health- and the creation of the global leader of consumer-centric health.
Alyssa Jaffee, Vice President of 7wireVentures, opens up about how COVID changed the investment landscape and how health tech startups can navigate the uncertain waters.
Livongo executive chairman Glen Tullman shares thoughts on the coronavirus impact on the business turning a profit in 2021.
Livongo announces pricing of upsized $475.0 million convertible senior notes offering.
The FDA gave Livongo an emergency use authorization to allow its blood glucose monitors to be used in hospitals, and has loosened requirements around the use of digital tools for mental health.
PWC Health Report Beyond IT: Why the regulatory push toward interoperability requires whole organizational responses from providers, payers
Lee Shapiro, Managing Partner at 7Wire Ventures shares his perspective on the state of interoperability within the healthcare system in this PWC Health Report.
Livongo forms partnership with Horizon Blue Cross Blue Shield of New Jersey and the State of New Jersey to provide Livongo for Diabetes to State and School Plan Members.
Livongo and Dexcom partner to integrate Dexcom’s continuous glucose monitoring system into Livongo’s applied health signals platform
This exciting partnership will now enable Livongo users to utilize data generated from Dexcom’s glucose monitoring system with other information tracked by the platform.
Livongo diabetes and hypertension solutions now available via Higi Smart Stations at major retailers
7Wire Ventures portfolio companies Higi and Livongo partner to meet consumers where they are and offer people living with chronic conditions a seamless, end-to-end experience.
2019 Venture-Backed Portfolio Company of the Year: Livongo!